.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent data from the FOURIER trial have addressed clinical concerns regarding low lipoprotein(a) safety in patients with atherosclerotic cardiovascular disease. While high levels of Lipoprotein(a) drive heart disease risk, many physicians worry about potential side effects from extremely low concentrations. Consequently, this secondary analysis focused on safety outcomes like bleeding and cognitive function in over 25,000 participants.
The study found no link between low Lp(a) levels and risks of haemorrhagic stroke, serious bleeding, or malignancy. Moreover, participants with levels as low as 13 nmol/L showed no increased incidence of atrial fibrillation or neurocognitive events. These results provide significant reassurance to clinicians. Specifically, the data suggest that aggressive lowering of this lipoprotein does not compromise neurological or vascular integrity.
However, the relationship with diabetes mellitus remains complex. While a lower baseline concentration was associated with a higher prevalence of diabetes, it did not predict a higher risk of developing new-onset diabetes during the trial. Therefore, the metabolic profile of these patients requires monitoring, yet the overall safety remains high. Furthermore, these findings support the continued development of targeted Lp(a) therapies.
Data show that while patients with naturally low Lp(a) may have a higher prevalence of diabetes at baseline, lowering Lp(a) with medication does not appear to increase the risk of developing new-onset diabetes.
Yes, the FOURIER trial indicates that very low levels of Lp(a) are not associated with increased risks of stroke, bleeding, cancer, or cognitive decline, supporting its long-term safety profile.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Always consult a qualified healthcare provider for personal health concerns. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A comprehensive analysis of the FOURIER trial confirms that low lipoprotein(a) levels are generally safe and do not increase risks of stroke or new diabetes...
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
